CD44 and glioblastoma: Hence, CD44+/CD133+/ITGA6+/CD36+ is the core signature that is consistently present in all seven gliomasphere systems as the common consensus multi‐marker combination – irrespective of the origin of the gliomasphere (stem‐like cell line, traditional glioblastoma cell line or patient‐derived).